Limited protection of GSK's malaria vaccine dwindles in 7 years

LONDON, June 29 (Reuters) - The world's first malaria vaccine, developed by GlaxoSmithKline, provides some protection after three doses but its effect dwindles to almost nothing after seven years, scientists said on Wednesday.